Beobachtungsplan, NIS 381: A non-interventional study to assess the safety and efficacy of first line therapy with Vectibix® in combination with FOLFIRI or FOLFOX and to validate a prognostic score in adult patients with RAS wild-type metastatic colorectal cancer in a real world setting (VALIDATE)

Datei

• Artikel "Beobachtungsplan, NIS 381: A non-interventional study to assess the safety and efficacy of first line therapy with Vectibix® in combination with FOLFIRI or FOLFOX and to validate a prognostic score in adult patients with RAS wild-type metastatic colorectal cancer in a real world setting (VALIDATE)"Herunterladen(PDF, 1MB, Datei ist nicht barrierefrei)